HIV-1整合酶链转移反应抑制剂的荧光筛选方法

中国生物工程杂志

2013, Vol. 33

Issue (1): 67-71

技术与方法

HIV-1整合酶链转移反应抑制剂的荧光筛选方法

刘斌¹, 刘昕¹, 李杉¹, 何红秋², 张小轶¹, 谭建军¹, 陈慰祖¹, 王存新¹

1. 北京工业大学生命科学与生物工程学院北京 100124;
2. 重庆市科学技术研究院重庆生物医药与器械研究中心重庆 401123

A Fluorescent Screening Assay for HIV-1 Integrase Inhibitors Targeting Strand Transfer

LIU Bin¹, LIU Xin¹, LI Shan¹, HE Hong-qiu², ZHANG Xiao-yi¹, TAN Jian-jun¹, CHEN Wei-zu¹, WANG Cun-xin¹

1. College of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China;
2. Chongqing Center for Biomedicines and Medical Equipment, Chongqing Academy of Science and Technology, Chongqing 401123, China

全文: PDF(539 KB) HTML

摘要： 整合酶被认为是抗HIV-1药物研究的理想靶点之一。为了建立便捷高效的整合酶链转移反应抑制剂筛选方法,首先将HIV-1整合酶原核表达载体pNL-IN转化入大肠杆菌感受态细胞BL21(DE3)进行原核表达,并用镍琼脂糖凝胶进行亲和纯化,获得了纯度和活性均较高的整合酶重组蛋白;然后设计了生物素标记的供体DNA和FITC标记的靶DNA,用链霉亲和素磁珠捕获反应体系中的DNA产物;最后用荧光分析仪检测DNA产物的荧光信号,并计算待测样品的抑制率。用已知整合酶抑制剂S-1360和MK-0518对筛选方法进行了验证,测定结果与已有实验数据相当,表明本筛选方法能够有效应用于HIV-1整合酶链转移反应抑制剂的筛选。与现有的整合酶链转移反应抑制剂筛选方法相比,本筛选方法步骤更为简化、耗时更短、成本更低。

关键词： HIV-1; 整合酶; 链转移; 抑制剂筛选

Abstract: HIV-1 integrase is an ideal target for anti-HIV-1 drug discovery. The aim of the present study was to develop a highly effective and more convenient screening assay for HIV-1 integrase inhibitors targeting strand transfer. First, the recombinant expression vector pNL-IN, which contains the HIV-1 integrase gene, was transformed into E. coli BL21 (DE3) competent cells for prokaryotic expression. The recombinant integrase protein was purified by affinity chromatography. It was validated that the recombinant integrase protein was pure and active for screening assay development. Then, the biotin-labeled donor DNA and the FITC-labeled target DNA were synthesized and applied in the assay, and streptavidin-coated magnetic beads were used to capture the product DNA in the reaction system. Finally, the fluorescence signal was detected by a fluorescence microplate reader for the calculation of sample activity. Two reported integrase inhibitors, S-1360 and MK-0518, were tested to validate the screening assay, and the results are in accordance with previous studies, which indicated that the screening assay could be used for the screening of integrase inhibitor targeting strand transfer. The screening assay for HIV-1 integrase inhibitors developed in the present study is more convenient, time-saving and cost-effective than previous screening assays.

Key words: HIV-1 Integrase Strand transfer Inhibitor screening

收稿日期: 2012-10-26 出版日期: 2013-01-25

ZTFLH:

Q819

基金资助: 科技部国际合作项目(2010DFA31710);国家自然科学基金(31100523,21173014);国家"973"计划(2009CB930200)资助项目

通讯作者: 王存新 E-mail: cxwang@bjut.edu.cn

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	刘斌
	刘昕
	李杉
	何红秋
	张小轶
	谭建军
	陈慰祖
	王存新

引用本文:

刘斌, 刘昕, 李杉, 何红秋, 张小轶, 谭建军, 陈慰祖, 王存新. HIV-1整合酶链转移反应抑制剂的荧光筛选方法[J]. 中国生物工程杂志, 2013, 33(1): 67-71.

LIU Bin, LIU Xin, LI Shan, HE Hong-qiu, ZHANG Xiao-yi, TAN Jian-jun, CHEN Wei-zu, WANG Cun-xin. A Fluorescent Screening Assay for HIV-1 Integrase Inhibitors Targeting Strand Transfer. China Biotechnology, 2013, 33(1): 67-71.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/ 或 https://manu60.magtech.com.cn/biotech/CN/Y2013/V33/I1/67

[1] Engelman A, Mizuuchi K, Craigie R. HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell, 1991, 67 (6): 1211-1221.
[2] Pluymers W, De C E, Debyser Z. HIV-1 integration as a target for antiretroviral therapy: a review. Current Drug Targets - Infectious Disorders, 2001, 1 (2): 133-149.
[3] Lataillade M, Kozal M J. The hunt for HIV-1 integrase inhibitors. AIDS Patient Care STDS, 2006, 20 (7): 489-501.
[4] 李敬云. HIV-1的耐药基因突变. 中国艾滋病性病, 2010, 16 (2): 195-197. Li J Y. HIV-1 drug resistance mutations. Chinese Journal of AIDS & STD, 2010, 16 (2): 195-197.
[5] Tang M W, Shafer R W. HIV-1 antiretroviral resistance: scientific principles and clinical applications. Drugs, 2012, 72 (9): e1-25.
[6] Hazuda D J. HIV integrase as a target for antiretroviral therapy. Current Opinion in HIV and AIDS, 2012, 7 (5): 383-389.
[7] Wainberg M A, Mesplède T, Quashie P K. The development of novel HIV integrase inhibitors and the problem of drug resistance. Current Opinion in Virology, 2012, 2 (5): 656-662.
[8] 王欣, 程绍辉. HIV整合酶抑制剂的应用及耐药研究进展. 中国艾滋病性病, 2012, 18 (6): 429-431. Wang X, Cheng SH H. Research progress in application of HIV-1 integrase inhibitor and drug resistance. Chinese Journal of AIDS & STD, 2012, 18 (6): 429-431.
[9] Chiu T K, Davies D R. Structure and function of HIV-1 integrase. Current Topics in Medicinal Chemistry, 2004, 4 (9): 965-977.
[10] Zeinalipour-Loizidou E, Nicolaou C, Nicolaides A, et al. HIV-1 integrase: from biology to chemotherapeutics. Current HIV Research, 2007, 5 (4): 365-388.
[11] Hazuda D J, Felock P, Witmer M, et al. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science, 2000, 287 (5453): 646-650.
[12] He H Q, Ma X H, Liu B, et al. A novel high-throughput format assay for HIV-1 integrase strand transfer reaction using magnetic beads. Acta Pharmacologica Sinica, 2008, 29 (3): 397-404.
[13] 何红秋, 程绍辉, 刘斌, 等. 用荧光方法检测 HIV-1整合酶的体外活性. 光散射学报, 2009, 21 (2): 185-189. He H Q, Cheng SH H, Liu B, et al. Detection of HIV-1 integrase in vitro activities using fluorescent technology. The Journal of Light Scattering, 2009, 21 (2): 185-189.
[14] Zhang J H, Chung T D Y, Oldenburg K R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Journal of Biomolecular Screening, 1999, 4 (2): 67-73.
[15] Inglese J, Johnson R L, Simeonov A, et al. High-throughput screening assays for the identification of chemical probes. Nature Chemical Biology, 2007, 3 (8): 466-479.
[16] Billich A. S-1360 Shionogi-GlaxoSmithKline. Current Opinion in Investigational Drugs, 2003, 4 (2): 206-209.
[17] Hombrouck A, Van Remoortel B, Michiels M, et al. Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors. Antimicrobial Agents and Chemotherapy, 2008, 52 (8): 2861-2869.
[18] 李芳琼, 丁倩, 詹金彪. HIV-1整合酶及其抑制剂的研究进展. 中国生物工程杂志, 2008, 28 (1): 80-86. Li F Q, Ding Q, Zhan J B. Progress in research on HIV-1 integrase and its inhibitors. China Biotechnology, 2008, 28 (1): 80-86.
[19] 郭涤亮, 刘冠男, 周宇, 等. HIV整合酶抑制剂的研究进展. 有机化学, 2010, 30 (4): 477-485. Guo D L, Liu G N, Zhou Y, et al. Research progress in HIV integrase inhibitors. Chinese Journal of Organic Chemistry, 2010, 30 (4): 477-485.
[20] Tan J J, Liu C, Sun X H, et al. Perspectives on developing small molecule inhibitors targeting HIV-1 integrase. Mini Reviews in Medicinal Chemistry, 2012, 12 (9): 875-889.
[21] He H, Liu B, Zhang X, et al. Development of a high-throughput assay for the HIV-1 integrase disintegration reaction. SCIENCE CHINA Life Sciences, 2010, 53 (2): 241-247.
[22] 何红秋, 贾渝跃. HIV-1整合酶核心区可溶性表达及抑制剂筛选. 中国生物工程杂志, 2012, 32 (3): 14-19. He H Q, Jia Y Y. Soluble expression and inhibitor screening of the central core domain of HIV- 1 integrase. China Biotechnology, 2012, 32 (3): 14-19.

[1]	聂永强, 马海燕, 马晴雯. 位点特异整合微环DNA的体内制备[J]. 中国生物工程杂志, 2017, 37(7): 80-87.
[2]	袁雅红, 赵珊珊, 王小莉, 腾智平, 李东升, 曾毅. HIV-1 Tat蛋白抑制骨髓间充质干细胞的造血支持功能[J]. 中国生物工程杂志, 2017, 37(6): 1-8.
[3]	王小莉, 余庆, 袁雅红, 腾智平, 李东升, 曾毅. 打靶恒河猴CD4⁺ T细胞的TRIM5α基因影响其感染HIV的能力[J]. 中国生物工程杂志, 2017, 37(2): 15-19.
[4]	朱羿龙, 李昌, 郭焱, 刘存霞, 杜寿文, 王茂鹏, 金宁一. *表达HIV-1 gag重组鸡痘病毒的构建与筛选*[J]. 中国生物工程杂志, 2014, 34(1): 57-63.
[5]	聂伦, 吴文言. RANTES衍生物与HIV-1进入抑制剂[J]. 中国生物工程杂志, 2013, 33(2): 96-102.
[6]	李建彬, 米志强, 安小平, 谭莉, 陈斌, 王晓娜, 范华昊, 张文慧, 张博, 方祥, 童贻刚. shRNA随机文库结合TK自杀基因筛选靶向HIV-1LTR相关宿主因子[J]. 中国生物工程杂志, 2012, 32(09): 48-54.
[7]	何红秋, 贾渝跃. HIV-1整合酶核心区可溶性表达及抑制剂筛选[J]. 中国生物工程杂志, 2012, 32(03): 14-19.
[8]	何红秋, 刘斌, 陈慰祖, 王存新. 分子信标方法研究HIV-1整合酶3'加工反应动力学[J]. 中国生物工程杂志, 2012, 32(02): 76-81.
[9]	王子晔, 冯娟, 马雪梅, 王明连, 钟儒刚. 利用噬菌体肽库筛选与HIV-1p24抗原结合的多肽[J]. 中国生物工程杂志, 2011, 31(5): 104-107.
[10]	王子晔冯娟马雪梅王明连钟儒刚. 利用噬菌体肽库筛选与HIV-1p24抗原结合的多肽[J]. 中国生物工程杂志, 2011, 31(05): 0-0.
[11]	曹志亮, 何玉先. HIV-1中和抗体和基于抗体的疫苗设计[J]. 中国生物工程杂志, 2010, 30(12): 105-110.
[12]	杨东刘斌何红秋张小轶张海锋许先进陈慰祖王存新. T66I突变提高HIV-1整合酶可溶性研究[J]. 中国生物工程杂志, 2010, 30(08): 17-21.
[13]	赵赫龙赵鹏翔李政马雪梅钟儒刚曾毅. HIV假病毒用于p24抗原检测试剂研制的研究[J]. 中国生物工程杂志, 2010, 30(08): 13-16.
[14]	杲光伟姚璎丁大中叶龙周虎臣李大伟. 以布氏锥虫亮氨酰tRNA合成酶为靶标的抗锥虫药物筛选系统的建立[J]. 中国生物工程杂志, 2009, 29(12): 13-17.
[15]	曲立娟,黄英. ΦC31整合酶与转基因动物研制[J]. 中国生物工程杂志, 2009, 29(02): 103-107.

Viewed

Full text

Abstract

Cited

Shared

Discussed